Main
Sir,
We report a case of inadvertent intraocular injection of depomedrone (methylprednisolone acetate 40 mg/ml). This is a rare complication of peribulbar steroid injection. The need for the procedure to be performed must be strongly assessed in view of the potential complication of perforation.
Case report
A 71-year-old gentleman underwent uneventful left cataract extraction and posterior chamber implant insertion in September 1999. He developed refractory cystoid macular oedema (CMO) 2 months postoperatively, unresponsive to topical/oral steroids and topical nonsteroidal anti-inflammatories. He started to develop osteoporotic joint symptoms while on oral steroids; hence the decision was made to perform a peribulbar steroid injection to reduce systemic steroid sideeffects. A sharp 25-gauge 16-mm needle was introduced transconjunctivally at the junction of the outer third and medial two-thirds of the lower orbital margin. Some resistance to insertion was experienced during needle entry. Aspiration check revealed no blood or fluid. A measure of 1 ml of depomedrone was injected. This was perceived by the patient to be uncomfortable at the time. The eye was then double padded and the patient was asked to keep the pad on till later that day.
The patient presented 24 h later, as an emergency, with reduced vision in the left eye. He reported that he was aware of floaters in the eye soon after the peribulbar injection. Visual acuity prior to the injection was 6/9, and was count fingers 24 h postinjection. Examination findings were a subconjunctival haemorrhage in the left inferior fornix; anterior chamber debris and white globules of depomedrone were noted floating in the vitreous with some coating the retina inferiorly (Figure 1). The IOP was 12 mmHg. He was commenced on oral ciprofloxacin and topical ofloxacin, atropine, and dexamethasone.
An ultrasound B scan was performed, which revealed vitreous detachment with a mobile subhyaloid collection (Figure 2). No retinal elevation was noted.
A pars plana vitrectomy was performed at the earliest available opportunity, which was just over 48 h after the perforation. Laser retinopexy to needle entry site and air/fluid/gas (C3F8) exchange was performed. Postoperative posturing was advised.
He underwent an uneventful postoperative recovery and his visual acuity gradually improved to 6/12 and N5 over a 2-month period. FFA performed 2 months postoperatively revealed persisting CMO. Visual acuity gradually recovered over the following 10 months to 6/9 with eventual resolution of the CMO.
Comments
Vitrectomy1 and intravitreal steroid injection (triamcinolone)2,3 have both been advocated in the management of refractory CMO. However in this case, neither the vitrectomy itself nor the intraocular steroid exposure seemed to have any beneficial effect on the CMO. In fact, the suggested safe dose for intraocular administration of the triamcinolone preparation is almost 20-fold less than that of the steroid injected in this case.4
To our knowledge, there have only been 13 cases of inadvertent intraocular depomedrone injections reported.5,6,7,8,9,10 Many were managed conservatively, which mostly lead to serious complications such as ascending optic atrophy.5,6 Vitrectomy has been regarded as the treatment of choice for the last 15 years or so. Previous reports advocate immediate vitrectomy to achieve better prognosis;10 our case was operated on over 48 h following the injection and the visual outcome was satisfactory. This suggests that the intraocular residence time of the depomedrone may not have an adverse effect on visual outcome, although longer residence times may be associated with an increased incidence of complications such as those noted in conservatively managed cases.
The incidence of perforation during peribulbar injection of local anaesthetic has been reported up to 1 in 874.11 In order to try and reduce perforation rates, alterations in technique have been suggested such as watching for corresponding globe movement whilst performing horizontal movements of the needle. This is done following needle insertion but prior to injection.12 The introduction of newer techniques of periocular steroid administration, such as blunt cannula subtenon injection, avoids the need to introduce a sharp instrument into the orbit, thereby reducing incidences of inadvertent ocular perforation.
References
Pendergast SD, Margherio RR, Williams GA, Cox MS Jr . Vitrectomy for chronic pseudophakic cystoid macular oedema. Am J Ophthalmol 1999; 128(3): 317–323.
Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TD, Marshall J . Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence study. Ophthalmology 2001; 108(4): 765–772.
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular odema. Ophthalmology 2002; 109(5): 920–927.
McCuen BW, Bessler M, Tano Y, Chandler P, Machemer R . The lack of toxicity of intravitreally administered triamcinolone acetate. Am J Ophthalmol 1981; 92: 625–627.
Giles CL . Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol 1974; 77: 438–441.
Schlaegel TF, Wilson FM . Accidental intraocular injection of depot corticosteroids. Ophthalmology (Rochester) 1974; 78: 847–855.
Zinn KM . Iatrogenic intraocular injection of Depocorticosteroid and its surgical removal using the pars plana approach. Ophthalmology (Rochester) 1981; 88: 13–17.
Moschicci GB . Incidental introduction of a long-acting corticosteroid in the vitreous humour. Boll Oculist 1969; 48: 426–432.
McLean EB . Inadvertent injection of corticosteroid into the choroidal vasculature. Am J Ophthalmol 1975; 80: 835–837.
Andrew NC, Gregor ZJ . Intraocular injection of Depomedrone. Br J Ophthalmol 1986; 70: 298–300.
Gillow JT, Aggarwal RK, Kirkby GR . A survey of ocular perforation during ophthalmic local anaesthetic in the United Kingdom. Eye 1996; 10: 537–538.
Kraushar MF, Cangemi FE, Morse PH . Prevention of accidental intraocular injection following inadvertent needle perforation of the eyeball. Ophthalmic Surg Lasers 1996; 27(5): 405–406.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gauba, V., Kelleher, S. & Raines, M. A case of inadvertent ocular perforation and intravitreal injection of depomedrone during peribulbar injection. Good visual prognosis with delayed vitrectomy. Eye 17, 1039–1040 (2003). https://doi.org/10.1038/sj.eye.6700510
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.eye.6700510
This article is cited by
-
Inadvertent intraocular injection of methylprednisolone in a patient with prior superior oblique tuck surgery
Spektrum der Augenheilkunde (2023)
-
Ocular perforation during peribular injection
Eye (2005)